Holen Sie sich die Stockscreener-App
5.08
9.84%
0.455
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
45.73%
2.70
|
4.9752 | 5.9861 | 3.2534 | 2.4094 |
| Operating Income/Loss |
45.73%
-2.70
|
-4.9752 | -5.9861 | -3.2534 | -2.4094 |
| Nonoperating Income/Loss |
193.51%
0.112
|
0.0382 | 0.0303 | 0.0349 | 0.0344 |
| Net Income/Loss |
47.58%
-2.588
|
-4.937 | -5.9558 | -3.2185 | -2.375 |
| Basic Average Shares |
911.31%
6.8382
|
0.6762 | - | 0.5589 | 0.3701 |
| Diluted Average Shares |
911.31%
6.8382
|
0.6762 | - | 0.5589 | 0.3701 |
| Basic Earnings Per Share |
94.79%
-0.38
|
-7.30 | - | -5.76 | -6.42 |
| Diluted Earnings Per Share |
94.79%
-0.38
|
-7.30 | - | -5.76 | -6.42 |
5.91%
2.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):